Profound Common Stock Total Equity from 2010 to 2026
| PROF Stock | USD 7.50 0.02 0.27% |
Common Stock Total Equity | First Reported 2014-09-30 | Previous Quarter 215.3 M | Current Value 219.1 M | Quarterly Volatility 68.8 M |
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 737.9 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
Profound | Common Stock Total Equity | Build AI portfolio with Profound Stock |
The Common Stock Total Equity trend for Profound Medical Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Profound Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Profound Medical's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Profound Medical Corp over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Profound Medical's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Profound Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 119,052,368 | |
| Geometric Mean | 38,904,043 | |
| Coefficient Of Variation | 82.58 | |
| Mean Deviation | 86,592,691 | |
| Median | 120,932,404 | |
| Standard Deviation | 98,310,348 | |
| Sample Variance | 9664.9T | |
| Range | 253.9M | |
| R-Value | 0.97 | |
| Mean Square Error | 638.1T | |
| R-Squared | 0.94 | |
| Slope | 18,856,210 | |
| Total Sum of Squares | 154638.8T |
Profound Common Stock Total Equity History
About Profound Medical Financial Statements
Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 243.3 M | 255.4 M |
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out the analysis of Profound Medical Correlation against competitors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.